The company said that the study evaluated the efficacy, safety and tolerability of an innovative, proprietary, 28mg memantine extended-release, once-daily formulation compared to placebo in outpatients with moderate
MetaCore is used for target identification, validation, biomarker discovery and knowledge mining. According to GeneGo, GlaxoSmithKline (GSK) will also use the platform as a repository of all types
Daniel Yarosh, president of AGI Dermatics, said: “The new products include our first retinol-based formulas and reinforce our commitment to harnessing the power of the industry’s most effective
The agreement will utilize DSM’s commercial facilities in Greenville, North Carolina. Howard Raff, COO of APT Pharmaceuticals, said: “DSM has a superior reputation in sterile manufacturing, experience with
This follows a favourable response from FDA, allowing Forest to initiate an additional Phase II study in COPD for Oglemilast (GRC 3886). Glenmark and Forest Labs are working
The BLA is based on data from more than 2,367 patients and includes three multi-center, placebo-controlled Phase III trials. In these studies Cimzia, given with methotrexate, was shown
The Matrix (A Phase IIb Study of GAM501 in the treatment of diabetic ulcers in the lower extremities) trial is a randomized, double-blind, placebo-controlled, comparator arm (standard of
Lpath will soon begin dosing patients in the first clinical study ever performed involving an antibody that inhibits a bioactive lipid. Lpath plans a multi-center Phase I open-label,
The collaboration will initially focus on two research programs. The first is a study on insulin resistant patients with a family history of type 2 diabetes. The primary
The technology includes analyzing gene expression change in RNA extracted from the bulb of cells located at the base of a single human plucked hair. The companies have
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.